ACHV
Achieve Life Sciences Inc
7.90$
+6.6%
vs. previous close
Closing price · As of: Sep 17, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Achieve Life Sciences Inc (ACHV) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 08/19/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/17/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 08/14/2026 | Current report (8-K) | ACHIEVE LIFE SCIENCES, INC. (ACHV): Other Events; Financial Statements and Exhibits | View report ↗ |
| 08/14/2026 | Capital measure | Form 424B5 filed with the SEC | View document ↗ |
| 08/13/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 08/11/2026 | Current report (8-K) | ACHIEVE LIFE SCIENCES, INC. (ACHV): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 07/27/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 07/08/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 07/06/2026 | Current report (8-K) | ACHIEVE LIFE SCIENCES, INC. (ACHV): Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.